Q1 2025 Earnings

Revenue

$8M+11.1% YoY

Gross Profit

$5M60.5% margin

Operating Income

-$6M-72.6% margin

Net Income

-$6M-71.0% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+9.2%

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$2M

Total Assets

$30M

Total Liabilities

$10M

Stockholders' Equity

$20M

Cash & Equivalents

$12M

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	+11.1%
Gross Profit	$5M	$5M	+13.4%
Operating Income	-$6M	-$4M	-45.7%
Net Income	-$6M	-$4M	-45.3%

Biologics And Drug Delivery

$5M63%

Biologics And Drug Delivery - Disposable Products

$2M24%

Capital Equipment And Software

$517,0007%

Capital Equipment And Software - Services

$283,0004%

Capital Equipment And Software - Systems and Software Products

$234,0003%